In this article, we will discuss Durvalumab (Dosage Modifications-5). So, let’s get started.
Endocrinopathies – Severity (Grade 3 or 4) – Withhold until clinically stable or permanently discontinue depending on severity.
In this article we will discuss Durvalumab (Dosage Modifications-5)